Cyclooxygenase-2 expression is a prognostic biomarker for non-small cell lung cancer patients treated with adjuvant platinum-based chemotherapy

Overview of attention for article published in World Journal of Surgical Oncology, February 2015

Altmetric Badge

Mentioned by

So far, Altmetric has seen 1 public wall post.

Background: Adjuvant chemotherapy after the resection of stage IB-IIIA non-small cell lung cancer (NSCLC) is now the standard…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity.